MSS
LLY icon

Mitchell Sinkler & Starr’s Eli Lilly LLY Stock Holding History

Mitchell Sinkler & Starr’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4M Sell
1,998
-85
-4% -$86.8K 1% 28
2026
Q1 		$1.92M Sell
2,083
-40
-2% -$40.6K 0.88% 38
2025
Q4 		$2.28M Sell
2,123
-305
-13% -$292K 1.03% 29
2025
Q3 		$1.85M Sell
2,428
-3
-0.1% -$2.23K 0.83% 37
2025
Q2 		$1.9M Buy
2,431
+30
+1% +$23.3K 0.91% 37
2025
Q1 		$1.98M Buy
2,401
+8
+0.3% +$6.66K 0.56% 48
2024
Q4 		$1.85M Sell
2,393
-673
-22% -$557K 0.49% 46
2024
Q3 		$2.41M Buy
3,066
+399
+15% +$359K 0.61% 41
2024
Q2 		$2.29M Sell
2,667
-1,135
-30% -$908K 0.59% 41
2024
Q1 		$2.96M Sell
3,802
-10,359
-73% -$7.37M 0.74% 39
2023
Q4 		$8.25M Buy
14,161
+5,704
+67% +$3.33M 1.5% 21
2023
Q3 		$4.54M Buy
8,457
+6,198
+274% +$3.19M 1.4% 23
2023
Q2 		$1.06M Sell
2,259
-254
-10% -$107K 0.3% 63
2023
Q1 		$863K Sell
2,513
-797
-24% -$269K 0.26% 75
2022
Q4 		$1.21M Buy
3,310
+35
+1% +$12.4K 0.39% 56
2022
Q3 		$1.06M Sell
3,275
-425
-11% -$135K 0.41% 56
2022
Q2 		$1.2M Hold
3,700
– – 0.44% 51
2022
Q1 		$1.06M Buy
3,700
+958
+35% +$247K 0.33% 60
2021
Q4 		$757K Sell
2,742
-600
-18% -$152K 0.22% 73
2021
Q3 		$772K Hold
3,342
– – 0.7% 53
2021
Q2 		$767K Hold
3,342
– – 0.7% 53
2021
Q1 		$624K Sell
3,342
-800
-19% -$156K 0.6% 57
2020
Q4 		$699K Hold
4,142
– – 0.67% 53
2020
Q3 		$613K Sell
4,142
-1,560
-27% -$241K 0.62% 54
2020
Q2 		$936K Hold
5,702
– – 1.06% 36
2020
Q1 		$791K Sell
5,702
-400
-7% -$55K 1.03% 35
2019
Q4 		$802K Sell
6,102
-1,410
-19% -$163K 0.85% 41
2019
Q3 		$840K Hold
7,512
– – 1.08% 36
2019
Q2 		$832K Sell
7,512
-330
-4% -$38.9K 0.95% 40
2019
Q1 		$1.02M Sell
7,842
-566
-7% -$68.8K 1.18% 33
2018
Q4 		$973K Sell
8,408
-2,658
-24% -$297K 1.2% 31
2018
Q3 		$1.19M Hold
11,066
– – 1.24% 31
2018
Q2 		$944K Sell
11,066
-373
-3% -$30.6K 1.04% 35
2018
Q1 		$885K Buy
+11,439
New +$921K 1.01% 40
2017
Q2 		– Sell
-2,475
Closed -$208K – 77
2017
Q1 		$208K Buy
+2,475
New +$198K 0.34% 76
2016
Q1 		– Sell
-2,475
Closed -$209K – 88
2015
Q4 		$209K Sell
2,475
-932
-27% -$77.3K 0.29% 86
2015
Q3 		$285K Hold
3,407
– – 0.37% 73
2015
Q2 		$284K Buy
3,407
+42
+1% +$3.2K 0.34% 77
2015
Q1 		$244K Hold
3,365
– – 0.27% 90
2014
Q4 		$232K Hold
3,365
– – 0.26% 85
2014
Q3 		$218K Hold
3,365
– – 0.24% 87
2014
Q2 		$209K Buy
+3,365
New +$201K 0.22% 87
2013
Q3 		– Sell
-38,767
Closed -$1.9M – 117
2013
Q2 		$1.9M Buy
+38,767
New +$2.11M 0.42% 59

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Mitchell Sinkler & Starr's LLY Position: Q2 2026 in Review

Mitchell Sinkler & Starr reduced its Eli Lilly (LLY) stake by 4.1% in Q2 2026, selling an estimated $86.8K and leaving 1,998 shares worth $2.4M. The position accounts for 1% of the portfolio, ranked #28.

Mitchell Sinkler & Starr first reported a position in LLY in Q2 2013 and has held it in 43 quarters since. The position peaked at $8.25M in Q4 2023. 1,537 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mitchell Sinkler & Starr held 1,998 shares of Eli Lilly worth $2.4M as of Q2 2026.
  • Mitchell Sinkler & Starr sold 85 Eli Lilly shares in Q2 2026, an estimated $86.8K.
  • Eli Lilly made up 1% of Mitchell Sinkler & Starr's portfolio in Q2 2026, its #28 holding.
  • Mitchell Sinkler & Starr first reported a position in Eli Lilly in Q2 2013 and has held it in 43 quarters since.
  • Mitchell Sinkler & Starr's Eli Lilly position peaked at $8.25M in Q4 2023.
  • 1,537 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mitchell Sinkler & Starr's 13F filing for Q2 2026, filed 21 Jul 2026.